Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Curaleaf Holdings, Inc. (CSE:CURA)(OTC: CURLF) has provided itself an additional revenue stream through the sale of six properties for $28.3 million.

Curaleaf Sells 6 Properties For $28.3M

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

CannTrust Holdings

GW Pharmaceuticals

Tilray Brands

Here's why marijuana stock market caps have gone up in smoke.

These 10 Pot Stocks Have Lost Nearly $21 Billion in Aggregate Value in 4 Months

Curaleaf Holdings, Inc. (CSE:CURA) (OTC: CURLF) announced Tuesday it has begun its initiative with the Veterans Cannabis Project, an organization that campaigns for legal access of medical cannabis for veterans via the Department of Veterans Affairs in Oregon.

Curaleaf Teams With Veterans Cannabis Project Initiative, Reaches Oregon

Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) said Monday it has closed the purchase of Glendale Greenhouse, which was announced at the end of June.

Curaleaf Expands Footprint, Closes Glendale Greenhouse Acquisition

The market clearly overreacted to Curaleaf's FDA letter.

A Dive Into Curaleaf's FDA Letter

Aurora Cannabis may be the industry's top producer, but these three marijuana stocks are expected to generate more in sales next year.

3 Pot Stocks That Can Outsell Aurora Cannabis in 2020

Cara Therapeutics

Neptune Wellness Solutions Inc.

Shopify

Scotts Miracle-Gro

While these nine pot stocks rose, 38 others ended lower by at least 10%.

Only These 9 Cannabis Stocks Rose in July

CVS Health

The U.S. Food and Drug Administration's harsh stance on cannabidiol should surprise no one.

The FDA Just Showed Its Hand on CBD -- Is It Time for Investors to Fold?

Green Thumb Industries Inc.

HEXO Corp

Innovative Industrial Properties

Trulieve Cannabis Corp.

These are the only cannabis stocks with a billion-dollar valuation.

The 13 Largest Marijuana Stocks in the World

Curaleaf's CBD Debacle And A Lesson For Investors

Vertically integrated, multi-state cannabis company Curaleaf Holdings Inc (OTC: CURLF) said Friday morning it addressed issues the U.S.

Curaleaf: Cannabis Sector 'Needs, Wants And Appreciates' FDA Oversight

Curaleaf says it scrubbed its website and social media accounts of claims about its CBD products in response to a warning from the Food and Drug Administration saying it was making illegal health claims.

Curaleaf scrubs CBD health claims from its pages in response to FDA warning

Massachusetts-based cannabis company Curaleaf Holdings Inc. CURLF, +0.68% CURA, +0.00% said Friday it has responded to a warning letter from the U.s.

Curaleaf says it has removed all CBD product claims that FDA said were non-compliant

Curaleaf Holdings, Inc. (CSE:CURA) (OTC: CURLF) announced Wednesday the opening of its 25th Florida dispensary.

Curaleaf Opens 25th Dispensary In Florida

The Food and Drug Administration issued an open "warning letter" Monday to Curaleaf Holdings Inc (OTC: CURLF) stating the vertically integrated cannabis operator is making illegal or false claims on its website and social media accounts.

Curaleaf Trades Lower After FDA Sends Warning On CBD Products

U.S. cannabis producer Curaleaf received a warning letter from the Food and Drug Administration saying several of its hemp CBD products are "unapproved new drugs" running afoul of the law
The post Marijuana Stocks Fall As FDA Sends Warning On Hot Cannabis Products appeared first on Investor's Business Daily.

Marijuana Stocks Fall As FDA Sends Warning On Hot Cannabis Products

The Food and Drug Administration issued a warning letter to Curaleaf for allegedly "illegally selling" CBD products with "unsubstantiated claims" like the products treating cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety.

FDA issues warning to Curaleaf for 'illegally selling' CBD products with 'unsubstantiated claims'

Curaleaf's acquisition of GR Companies bringing it tremendous exposure.

Curaleaf Holdings Becoming Face Of U.S. Cannabis Sector - Why It Matters

Curaleaf announced another game-changing merger with Grassroots to expand its MSO scale.

Curaleaf: Shocking Market Leader

Curaleaf's $875 million deal to buy Grassroots shakes up the multistate dispensary leaderboard.

A Comprehensive Look at U.S. Dispensary Stocks Following Curaleaf's Big Acquisition

Curaleaf is buying expansion with its $875 acquisition of Grassroots. Meanwhile, OrganiGram reported Q3 results, and Aurora Cannabis had a good news/bad news week.

Weekly Cannabis Stock News: Curaleaf Makes a Power Play

Curaleaf's acquisitions are dramatically expanding its footprint to exploit the market's exploding growth.

Curaleaf's Plan To Become No. 1 in Cannabis

CRISPR Therapeutics

CRISPR Therapeutics and Curaleaf Holdings could have a lot more room to run.

2 Supercharged Growth Stocks I'd Buy Right Now

Curaleaf reported 2019 Q1 results which showed significant slowdown in revenue growth after a period of rapid growth.

Curaleaf: Zero In On Aggressive 2019 Revenue Target

The company will be the new owner of GR Companies (Grassroots).

Curaleaf Makes an $875 Million Deal, Stock Up 17.5%

News for Curaleaf Holdings, Inc. Stock (CURLF)